S. Slavin, A. Nagler, E. Naparstek, Y. Kapelushnik, M. Aker et al., Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases, Blood, vol.91, pp.756-63, 1998.

P. Mcsweeney, D. Niederwieser, J. Shizuru, B. Sandmaier, A. Molina et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, vol.97, issue.11, pp.3390-400, 2001.
DOI : 10.1182/blood.V97.11.3390

S. Giralt, E. Estey, M. Albitar, K. Van-besien, G. Rondón et al., Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versusleukemia without myeloablative therapy, Blood, vol.89, pp.4531-4567, 1997.

E. Fuchs, HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide, Bone Marrow Transplantation, vol.15, issue.S2, pp.31-36
DOI : 10.1126/scitranslmed.3003509

L. Luznik, O. Donnell, P. Symons, H. Chen, A. Leffell et al., HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.14, issue.6, pp.641-50, 2008.
DOI : 10.1016/j.bbmt.2008.03.005

A. Munchel, C. Kesserwan, H. Symons, L. Luznik, Y. Kasamon et al., HLAhaploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. Pediatr Rep, p.15, 2011.

C. Kanakry, O. Donnell, P. Furlong, T. De-lima, M. Wei et al., Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning, Journal of Clinical Oncology, vol.32, issue.31, pp.3497-505, 2014.
DOI : 10.1200/JCO.2013.54.0625

C. Kanakry, H. Tsai, J. Bolaños-meade, B. Smith, I. Gojo et al., Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS, Blood, vol.124, issue.25, pp.3817-3844, 2014.
DOI : 10.1182/blood-2014-07-587477

E. Jacoby, A. Chen, D. Loeb, C. Gamper, E. Zambidis et al., Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen???Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies, Biology of Blood and Marrow Transplantation, vol.22, issue.1, pp.112-130, 2016.
DOI : 10.1016/j.bbmt.2015.08.034

A. Raiola, A. Dominietto, A. Ghiso, D. Grazia, C. Lamparelli et al., Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning, Biology of Blood and Marrow Transplantation, vol.19, issue.1, pp.117-139, 2013.
DOI : 10.1016/j.bbmt.2012.08.014

P. Chevallier, M. Labopin, G. Socié, R. Tabrizi, S. Furst et al., Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial, Haematologica, vol.99, issue.9, pp.1486-91, 2014.
DOI : 10.3324/haematol.2014.108563

URL : https://hal.archives-ouvertes.fr/hal-01325352

S. Farhan, E. Peres, and N. Janakiraman, Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow???Review of Published Literature, Advances in Hematology, vol.90, issue.5, p.6950346, 2016.
DOI : 10.3324/haematol.2009.006924

Y. Chang, X. Zhao, and X. Huang, Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.20, issue.4, pp.440-489, 2014.
DOI : 10.1016/j.bbmt.2013.11.028

A. Roberto, L. Castagna, V. Zanon, S. Bramanti, R. Crocchiolo et al., Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation, Blood, vol.125, issue.18, pp.2855-64, 2015.
DOI : 10.1182/blood-2014-11-608406

C. Kanakry, D. Coffey, A. Towlerton, A. Vulic, B. Storer et al., Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide, JCI Insight, vol.1, issue.5, p.86252, 2016.
DOI : 10.1172/jci.insight.86252DS1

M. Rubio, M. Labopin, D. Blaise, G. Socié, R. Contreras et al., The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Haematologica, vol.100, issue.5, pp.683-89, 2015.
DOI : 10.3324/haematol.2014.119339

M. Alizadeh, M. Bernard, B. Danic, C. Dauriac, B. Birebent et al., Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction, Blood, vol.99, issue.12, pp.4618-4643, 2002.
DOI : 10.1182/blood.V99.12.4618

P. Chevallier, I. Hebia-fellah, L. Planche, T. Guillaume, C. Bressolette-bodin et al., Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source, Bone Marrow Transplantation, vol.100, issue.7, pp.1204-1215, 2010.
DOI : 10.1002/jmv.20760

A. Bashey, X. Zhang, C. Sizemore, K. Manion, S. Brown et al., T-Cell???Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation, Journal of Clinical Oncology, vol.31, issue.10, pp.1310-1326, 2013.
DOI : 10.1200/JCO.2012.44.3523

A. Raiola, A. Dominietto, C. Di-grazia, T. Lamparelli, F. Gualandi et al., Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts, Biology of Blood and Marrow Transplantation, vol.20, issue.10, pp.1573-79, 2014.
DOI : 10.1016/j.bbmt.2014.05.029

URL : https://doi.org/10.1016/j.bbmt.2014.05.029

S. Ciurea, M. Zhang, A. Bacigalupo, A. Bashey, F. Appelbaum et al., Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood, vol.126, issue.8, pp.1033-1073, 2015.
DOI : 10.1182/blood-2015-04-639831

A. Ruggeri, M. Labopin, G. Sanz, S. Piemontese, W. Arcese et al., Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, vol.90, issue.9, pp.1891-900, 2015.
DOI : 10.1182/blood-2008-02-140095

D. Blaise, S. Fürst, R. Crocchiolo, J. El-cheikh, A. Granata et al., Haploidentical T Cell???Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen???Matched Related or Unrelated Donor, Biology of Blood and Marrow Transplantation, vol.22, issue.1, pp.119-143, 2016.
DOI : 10.1016/j.bbmt.2015.08.029

A. Rashidi, M. Slade, J. Dipersio, P. Westervelt, R. Vij et al., Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML, Bone Marrow Transplantation, vol.30, issue.12, pp.1561-64, 2016.
DOI : 10.1155/2016/4025073

R. Mehta, R. Saliba, J. Chen, G. Rondon, A. Hammerstrom et al., Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation, British Journal of Haematology, vol.17, issue.Suppl. 3, pp.444-55, 2016.
DOI : 10.1016/j.bbmt.2010.09.012

S. Gaballa, I. Ge, E. Fakih, R. Brammer, J. Kongtim et al., Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation, Cancer, vol.120, issue.suppl 1, pp.3316-3342, 2016.
DOI : 10.1182/blood-2012-03-418202

A. Desjonqueres, M. Illiaquer, A. Duquesne, L. Bris, Y. Peterlin et al., Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation, Bone Marrow Transplantation, vol.15, issue.8, pp.1150-52, 2016.
DOI : 10.1200/JCO.1997.15.5.1767

P. Peterlin, J. Delaunay, T. Guillaume, T. Gastinne, B. Mahé et al., Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults, Biology of Blood and Marrow Transplantation, vol.21, issue.1, pp.180-84, 2015.
DOI : 10.1016/j.bbmt.2014.08.018

L. Pascal, L. Tucunduva, A. Ruggeri, D. Blaise, P. Ceballos et al., Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation, Blood, vol.126, issue.8, pp.1027-1059, 2015.
DOI : 10.1182/blood-2014-09-599241

M. Baker, H. Wang, S. Rowley, L. Cai, A. Pecora et al., Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies, Biology of Blood and Marrow Transplantation, vol.22, issue.11, pp.2047-55, 2016.
DOI : 10.1016/j.bbmt.2016.08.003

H. Nakamae, H. Koh, T. Katayama, M. Nishimoto, Y. Hayashi et al., HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome, Experimental Hematology, vol.43, issue.11, pp.921-929, 2015.
DOI : 10.1016/j.exphem.2015.07.006

R. Crocchiolo, L. Giordano, A. Rimondo, M. Bologna, B. Sarina et al., Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor, Journal of Clinical Virology, vol.84, pp.24-26, 2016.
DOI : 10.1016/j.jcv.2016.09.008

Y. Chang, X. Zhao, and X. Huang, Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies, Biology of Blood and Marrow Transplantation, vol.14, issue.3, pp.323-357, 2008.
DOI : 10.1016/j.bbmt.2007.12.497

Y. Chang, X. Zhao, M. Huo, L. Xu, D. Liu et al., Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies, American Journal of Hematology, vol.86, issue.2, pp.227-257, 2011.
DOI : 10.1002/ajh.21921

Y. Chang, X. Zhao, M. Huo, L. Xu, D. Liu et al., Immune Reconstitution Following Unmanipulated HLA-Mismatched/Haploidentical Transplantation Compared with HLA-Identical Sibling Transplantation, Journal of Clinical Immunology, vol.14, issue.2, pp.268-80, 2012.
DOI : 10.1016/j.bbmt.2008.07.014

S. Ciurea, V. Mulanovich, R. Saliba, U. Bayraktar, Y. Jiang et al., Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.18, issue.12, pp.1835-1879, 2012.
DOI : 10.1016/j.bbmt.2012.07.003

Y. Chang, X. Zhao, L. Xu, D. Liu, K. Liu et al., Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome, Leukemia & Lymphoma, vol.85, issue.12, pp.2671-77, 2013.
DOI : 10.1002/eji.201040793

R. Azevedo, M. Soares, A. Albuquerque, R. Tendeiro, R. Soares et al., Long-Term Immune Reconstitution of Naive and Memory T??Cell Pools after Haploidentical Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.19, issue.5, pp.703-715, 2013.
DOI : 10.1016/j.bbmt.2013.01.017

B. Park, C. Park, S. Jang, H. Chi, D. Kim et al., Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients, Leukemia Research, vol.39, issue.12, pp.1334-1375, 2015.
DOI : 10.1016/j.leukres.2015.09.010

D. Tian, Y. Wang, X. Zhang, K. Liu, X. Huang et al., Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation, PLOS ONE, vol.88, issue.6, p.156777, 2016.
DOI : 10.1371/journal.pone.0156777.s001

L. Bourgeois, A. Lestang, E. Guillaume, T. Delaunay, J. Ayari et al., Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT), European Journal of Haematology, vol.38, issue.3, pp.177-86, 2013.
DOI : 10.3109/10428190009087014

L. Bourgeois, A. Peterlin, P. Guillaume, T. Delaunay, J. Duquesne et al., Higher Early Monocyte and Total Lymphocyte Counts Are??Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood??Allogeneic Stem Cell Transplantation in Adults, Biology of Blood and Marrow Transplantation, vol.22, issue.8, pp.1473-79, 2016.
DOI : 10.1016/j.bbmt.2016.04.015

M. Rubio, L. Moreira-teixeira, E. Bachy, M. Bouillié, P. Milpied et al., Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival, Blood, vol.120, issue.10, pp.2144-54, 2012.
DOI : 10.1182/blood-2012-01-404673

T. Santolaria, M. Robard, A. Léger, V. Catros, M. Bonneville et al., Repeated Systemic Administrations of Both Aminobisphosphonates and Human V??9V??2 T Cells Efficiently Control Tumor Development In Vivo, The Journal of Immunology, vol.191, issue.4, pp.1993-2000, 2013.
DOI : 10.4049/jimmunol.1300255

P. Chevallier, M. Labopin, L. De, R. Tour, B. Lioure et al., Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS, Cancer Medicine, vol.13, issue.11, pp.3068-76, 2016.
DOI : 10.2174/15680096113139990005

A. Ruggeri, Y. Sun, M. Labopin, A. Bacigalupo, F. Lorentino et al., -host disease prophylaxis in haploidentical transplant, Haematologica, vol.102, issue.2, pp.401-411, 2017.
DOI : 10.3324/haematol.2016.151779